Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 3, 2009, Dr. Goran Ando provided notice of his resignation from the Board of Directors (the "Board") of Enzon Pharmaceuticals, Inc. ("Enzon"). Dr. Ando cited the substantial time commitment required by a director and stated that he could not commit that time going forward, particularly in consideration of his geographic base in Europe. Dr. Ando stated "I have been on the board for 4.5 years and during that time I have seen Enzon face and overcome several challenges and emerge as a company with stable or growing sales and a promising pipeline. Jeff Buchalter and his management team should be proud of their achievements. It is truly a remarkable turnaround. It is now time for others to continue with the board work to help and support and guide management. I wish Enzon and its management team every possible success in the future."

In addition, on August 4, 2009, the Board adopted a resolution to reduce the size of the Board from nine to eight directors, eliminating the Class II vacancy created by Dr. Ando's resignation.

---